Ключевые слова:
MTHFR C677T polymorphism; diabetic polyneuropathy; homocysteine; folate metabolism; genetic risk factor; peripheral neuropathy.Библиографические ссылки
1. Bhatt DL, et al. Oxidative stress and homocysteine in cardiovascular and neurological disease. J Lab Clin Med. 2002;140(2):78–86.
2. Froese DS, Gravel RA. Genetic disorders of vitamin B12 metabolism: eight complementation groups — eight genes. Expert Rev Mol Med. 2010; 12:e37. doi:10.1017/S1462399 410001651.
3. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113. doi:10.1038/ng0595-111.
4. González R, Pedro T, Martínez-Hervás S, et al. Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects. J Peripher Nerv Syst. 2012; 17:191–196.
5. Heidari F, Rabizadeh S, Rajab A, et al. The MTHFR C677T polymorphism influences the efficacy of folic acid supplementation on the nerve conduction studies in patients with diabetic polyneuropathy. J Res Med Sci. 2019;24:44. PMC ID: PMC6521607. URL: https://pmc.ncbi.nlm.nih. gov/articles/PMC6521607/
6. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels: IDF; 2021. URL: https://diabetesatlas.org
7. Khodaeian M, Enayati S, Tabatabaei-Malazy O, Amoli MM. Association between MTHFR variant and diabetic neuropathy. Pharmacol Rep. 2017;69(5):973–978. doi:10.1016/j.pharep. 2017.04.017. URL: https://link.springer.com/article/10.1016/j.pharep.2017.04.017.
8. Khodaeian M, et al. Association between MTHFR variant and diabetic neuropathy. Pharmacol Rep. 2017;69(5):973–978. [17] ga qarang.
9. Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015; 58(1): 1–10. doi:10.1016/j.ejmg.2014.10.004. PubMed PMID: 25449138.
10. Liew SC, Gupta ED. Op. cit. [5].
11. Nazki FH, Sameer AS, Ganaie BA. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533(1):11–20.
12. Popa AM, Timar R, Timar B, et al. Genetic Variants Influence the Development of Diabetic Neuropathy. Int J Mol Sci. 2024;25(12):6429. doi:10.3390/ijms25126429. URL: https://www.mdpi .com/1422-0067/25/12/6429
13. Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci. 2009;66(14):2249–2261.
14. Quinlivan EP, McPartlin J, McNulty H, et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet. 2002;359(9302):227–228.
15. Rossi E, Costa M, et al. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. J Endocrinol Invest. 2015; 38(8):869–874. doi:10.1007/s40618-015-0365-9. URL: https://link. springer.com/article/10.1007/s40618-015-0365-9
16. Setacci C, De Donato G, Setacci F, Chisci E. Diabetic patients: epidemiology and global impact. J Cardiovasc Surg (Torino). 2009;50(3):263–273.
17. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62(5):1258–1260.
18. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999; 19:217–246. doi:10.1146/ annurev.nutr.19.1.217.
19. Said G. Diabetic neuropathy — a review. Nat Clin Pract Neurol. 2007;3(6):331–340. doi:10.1038/ncpneuro0504.
20. Stanger O, Fowler B, Pietrzik K, et al. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother. 2009; 9(9):1393–1412.
21. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293. doi:10.2337/dc10-1303. PubMed PMID: 20876709.
22. Veronika R, et al. MTHFR C677T polymorphism distribution in Central Asian populations. Mol Biol. 2020; 54:312–318.
23. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325(7374):1202. doi:10.1136/bmj.325.7374.1202.
24. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338(15):1042–1050. doi:10.1056/NEJM199804093381507.
25. Xuan C, Ji ZG, Li ZH, Zhao JX. Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis. Mol Neurobiol. 2016; 53(4):2435–2441. doi:10.1007/s12035-016-9823-4. URL: https://link.springer.com/article/10.1007/ s12035-016-9823-4.
26. Yigit S, Karakus N, Inanir A. Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy. Mol Vis. 2013; 19:1626–1630. PMC ID: PMC3724957. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3724957/
